Human Interaction Network Ontology

Last uploaded: June 27, 2014
Id http://purl.obolibrary.org/obo/HINO_0009684
http://purl.obolibrary.org/obo/HINO_0009684
Preferred Name

Inactivation of over-expressed wild type EGFR by Cetuximab recombinant antibody

Definitions
Cetuximab binds to the extracellular domain of EGFR and blocks ligand binding, leading to receptor inactivation, internalization and degradation. Cetuximab is approved for combination therapy and monotherapy of metastatic colorectal cancer and advanced squamous cell carcinoma of head and neck in patients whose tumors over-express wild-type EGFR protein, usually due to amplification of EGFR gene. Edited: Wu, G, 2011-11-07 Authored: Orlic-Milacic, M, 2011-11-04 Edited: D'Eustachio, P, 2011-11-07 Edited: Matthews, L, 2011-11-07 Reviewed: Greulich, H, 2011-11-15 Reviewed: Savas, S, 2011-11-15
Type http://www.w3.org/2002/07/owl#Class
Delete Subject Author Type Created
No notes to display